The Anti-PD-1 MAb Market in the US is expanding as immune checkpoint inhibitors become increasingly important in cancer treatment. Anti-PD-1 monoclonal antibodies (MAbs) work by blocking the programmed cell death protein 1 (PD-1) pathway, helping restore T-cell activity and enhance the immune system’s ability to recognize and attack cancer cells. Market Overview The anti-PD-1 mAb market...

The Metastatic Pancreatic Cancer Treatment Market in the US is expanding as healthcare providers focus on improving treatment options for patients with pancreatic cancer that has spread to distant organs. Market Overview The global metastatic pancreatic cancer treatment market size is projected to reach US$ 6.26 billion by 2034 from US$ 3.77 billion in 2025. The market is anticipated to...

The Antibody Purification Services Market in the US is expanding as pharmaceutical companies, biotechnology firms, academic institutions, and research organizations increasingly outsource antibody purification activities to specialized service providers. Market Overview The Antibody Purification Services market size is set to continue due to growing significance of outsourcing in purification...

The Research Antibodies and Reagent Market in the US is expanding as pharmaceutical companies, biotechnology firms, academic institutions, and research laboratories increasingly utilize antibodies and reagents across life sciences research, drug discovery, molecular biology, proteomics, and cell-based studies. Market Overview The Research Antibodies and Reagent Market size is expected to reach...

The Soft Elastic Capsule Market in the US is expanding as pharmaceutical, nutraceutical, and dietary supplement manufacturers increasingly adopt soft elastic capsules for delivering active ingredients in convenient oral dosage forms. Market Overview The Soft Elastic Capsule Market size is expected to reach US$ 5.26 Billion by 2034 from US$ 2.93 Billion in 2025. The market is estimated to record...

The Oncology Companion Diagnostics Market in North America is witnessing steady growth as healthcare providers increasingly utilize companion diagnostic tests to identify cancer biomarkers and guide the selection of targeted therapies. Growing adoption of personalized oncology, increasing investment in cancer research, expanding use of molecular testing, and advances in genomic...

The  Plasma Therapeutics Market in North America  is witnessing steady growth as plasma-derived therapies are increasingly utilized for the treatment and management of rare, chronic, immune-related, and bleeding disorders. Market Overview The Plasma Therapeutics Market size is expected to reach US$ 50.71 Billion by 2034 from US$ 29.1 Billion in 2025. The market is estimated...

The Hyaluronic Acid Products Market in North America is witnessing steady growth as hyaluronic acid-based products gain increasing adoption across healthcare, cosmetics, and personal care applications. Market Overview Hyaluronic Acid Products market size is expected to reach US$ 23.97 Billion by 2034 from US$ 10.51 Billion in 2025. The market is anticipated to register a CAGR of...

The Angiotensin Receptor Antagonists Market in North America is witnessing steady growth as healthcare providers increasingly utilize angiotensin receptor blockers (ARBs) for the management of hypertension and cardiovascular and renal conditions. Market Overview The Angiotensin Receptor Antagonists Market was valued at US$ 15,454.06 Million in 2025 and is expected to reach...

The Prostate Cancer Therapeutics Drugs Market in North America is witnessing steady growth as healthcare providers increasingly utilize pharmacological therapies to treat and manage prostate cancer across different stages of the disease. Market Overview The Prostate Cancer Therapeutics Drugs Market size is expected to reach US$ 44.54 Billion by 2034 from US$ 19.27 Billion in...